Performance vs S&P 500

03
Tracked Q4 2025–Q2 2026 -12.6%
S&P 500 total return (same window) +8.7%
Excess return -21.3%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 100.0% · Options excluded: 0.0%

Sector breakdown

04
Healthcare 75.5%
Other/Unmapped 24.5%

Full portfolio 8 positions

05
Type Streak 8Q trend
KMTS Kestra Medical Technologies, Ltd. - Common Stock $69,417,594 33.62% 2,728,679 $15,702,417 Up ×2
MLYS Mineralys Therapeutics, Inc. - Common Stock $42,949,921 20.80% 1,591,917 $-175,111
Unknown issuer (CUSIP: 05348Y105) $30,609,806 14.82% 929,824 Up ×1
AGMB AgomAb Therapeutics NV - ADRs representing one common share. $19,972,352 9.67% 1,538,702 $3,831,368
EVMN Evommune, Inc. Common Stock $18,499,547 8.96% 1,391,990 $-25,120,805 Down ×1
IVA Inventiva S.A. - American Depository Shares $13,733,424 6.65% 3,633,181 $3,642,519 Up ×1
ABVX Abivax SA - American Depositary Shares $10,410,938 5.04% 78,125 $1,711,719
NYXH Nyxoah SA - Ordinary Shares $882,276 0.43% 522,057 $-642,130

Biggest new bets

09

New positions opened this quarter, largest first.

SecurityValueShares% of portfolio
Unknown issuer (CUSIP: 05348Y105) $30,609,806 929,824 14.82%

Top movers (QoQ)

10
SecurityActionShares ΔValue Δ
EVMN Trimmed -505K -$25.1M
KMTS Bought more +33K +$15.7M
AGMB Price move only +0 +$3.8M
IVA Bought more +1.8M +$3.6M
ABVX Price move only +0 +$1.7M
NYXH Price move only +0 -$642K
MLYS Price move only +0 -$175K